Overall, we observed that anti-SARS-CoV-2 IgA and IgM antibodies decay rapidly after the acute infection phase (i.e., at month 3, 54% for IgA and 77% for IgM showed levels below the limit of detection) but the decline of IgG was less prominent and persisted until month 6. The gene discussed is CD40LG; the disease is infection.